Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Geron Corporation Reports Fourth Quarter And Annual 2006 Financial Results And Highlights
April 4th, 2007
Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and year ended December 31, 2006. As disclosed on March 9, 2007, the company has restated its consolidated balance sheets as of December 31, 2005, 2004 and 2003 as well as its consolidated statements of operations for the corresponding periods to reflect a change in the classification of warrants issued to investors in connection with equity financings. Restatement of Previously Reported Consolidated Financial Statements The restatement results from our review of recent guidance relating to Emerging Issues Task Force Issue 00-19, "Accounting for Derivative...
Source: Vaccine Weekly (2007-04-04)
|
